Soligenix
SNGX
#11002
Rank
C$10.28 M
Marketcap
C$0.47
Share price
0.51%
Change (1 day)
-75.25%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -C$16.13 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$16.71 Million a decrease over its 2024 earnings that were of -C$13.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$16.13 Million-3.47%
2025 -C$16.71 Million26.72%
2024 -C$13.19 Million22.96%
2023 -C$10.72 Million-45.74%
2022 -C$19.76 Million11.88%
2021 -C$17.66 Million-32.37%
2020 -C$26.11 Million83.18%
2019 -C$14.26 Million11.57%
2018 -C$12.78 Million19.29%
2017 -C$10.71 Million33%
2016 -C$8.06 Million-19.7%
2015 -C$10.03 Million5.16%
2014 -C$9.54 Million
2010 -C$10.77 Million26.12%
2009 -C$8.54 Million75.1%
2008 -C$4.88 Million-45.38%
2007 -C$8.93 Million-22.84%
2006 -C$11.57 Million66.15%
2005 -C$6.96 Million-16.65%
2004 -C$8.35 Million13.28%
2003 -C$7.37 Million-11.88%
2002 -C$8.37 Million-59.44%
2001 -C$20.63 Million378.18%
2000 -C$4.32 Million-38.53%
1999 -C$7.02 Million-18.43%
1998 -C$8.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.39 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.73 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.09 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$25.6 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$58.89 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.26 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.89 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.14 Billion 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA